Suppr超能文献

免疫细胞迁移、淋巴管与高血压。

Immune cell trafficking, lymphatics and hypertension.

机构信息

Department of Medical Physiology, Texas A&M College of Medicine, College Station, TX, USA.

出版信息

Br J Pharmacol. 2019 Jun;176(12):1978-1988. doi: 10.1111/bph.14370. Epub 2018 Jun 25.

Abstract

Activated immune cell infiltration into organs contributes to the development and maintenance of hypertension. Studies targeting specific immune cell populations or reducing their inflammatory signalling have demonstrated a reduction in BP. Lymphatic vessels play a key role in immune cell trafficking and in resolving inflammation, but little is known about their role in hypertension. Studies from our laboratory and others suggest that inflammation-associated or induction of lymphangiogenesis is organ protective and anti-hypertensive. This review provides the basis for hypertension as a disease of chronic inflammation in various tissues and highlights how renal lymphangiogenesis is a novel regulator of kidney health and BP. LINKED ARTICLES: This article is part of a themed section on Immune Targets in Hypertension. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v176.12/issuetoc.

摘要

免疫细胞浸润到器官中会导致高血压的发生和维持。针对特定免疫细胞群或减少其炎症信号的研究表明,血压会降低。淋巴管在免疫细胞运输和炎症解决中起着关键作用,但它们在高血压中的作用知之甚少。我们实验室和其他实验室的研究表明,与炎症相关或诱导淋巴管生成具有器官保护和抗高血压作用。这篇综述为高血压作为各种组织中慢性炎症的一种疾病提供了依据,并强调了肾脏淋巴管生成如何成为肾脏健康和血压的新调节因子。

相关文章

本文是免疫靶点在高血压中的一个专题部分的一部分。要查看该部分的其他文章,请访问 http://onlinelibrary.wiley.com/doi/10.1111/bph.v176.12/issuetoc.

相似文献

1
Immune cell trafficking, lymphatics and hypertension.
Br J Pharmacol. 2019 Jun;176(12):1978-1988. doi: 10.1111/bph.14370. Epub 2018 Jun 25.
2
Monocytes as immune targets in arterial hypertension.
Br J Pharmacol. 2019 Jun;176(12):1966-1977. doi: 10.1111/bph.14389. Epub 2018 Jul 14.
4
Immunity and hypertension: New targets to lighten the pressure.
Br J Pharmacol. 2019 Jun;176(12):1813-1817. doi: 10.1111/bph.14659.
5
Role of immune cells in hypertension.
Br J Pharmacol. 2019 Jun;176(12):1818-1828. doi: 10.1111/bph.14427. Epub 2018 Jul 20.
6
Targeting toll-like receptor 4 signalling pathways: can therapeutics pay the toll for hypertension?
Br J Pharmacol. 2019 Jun;176(12):1864-1879. doi: 10.1111/bph.14438. Epub 2018 Aug 9.
7
The role of autoimmune reactivity induced by heat shock protein 70 in the pathogenesis of essential hypertension.
Br J Pharmacol. 2019 Jun;176(12):1829-1838. doi: 10.1111/bph.14334. Epub 2018 May 22.
8
The bidirectional interaction between the sympathetic nervous system and immune mechanisms in the pathogenesis of hypertension.
Br J Pharmacol. 2019 Jun;176(12):1839-1852. doi: 10.1111/bph.14481. Epub 2018 Sep 25.
9
Salt, inflammation, IL-17 and hypertension.
Br J Pharmacol. 2019 Jun;176(12):1853-1863. doi: 10.1111/bph.14359. Epub 2018 Jun 15.

引用本文的文献

1
Hypertension: a lymphatic disease?
Clin Sci (Lond). 2025 Jun 23;139(12):597-603. doi: 10.1042/CS20245149.
2
The immune regulatory role of lymphangiogenesis in kidney disease.
J Transl Med. 2024 Nov 22;22(1):1053. doi: 10.1186/s12967-024-05859-4.
3
Sodium, Interstitium, Lymphatics and Hypertension-A Tale of Hydraulics.
Hypertension. 2024 Apr;81(4):727-737. doi: 10.1161/HYPERTENSIONAHA.123.17942. Epub 2024 Feb 22.
4
Abnormal Lymphatic Sphingosine-1-Phosphate Signaling Aggravates Lymphatic Dysfunction and Tissue Inflammation.
Circulation. 2023 Oct 17;148(16):1231-1249. doi: 10.1161/CIRCULATIONAHA.123.064181. Epub 2023 Aug 23.
5
Abnormal lymphatic S1P signaling aggravates lymphatic dysfunction and tissue inflammation.
medRxiv. 2023 Jun 12:2023.06.08.23291175. doi: 10.1101/2023.06.08.23291175.
6
Novel avenues to control blood pressure: targeting the renal lymphatic system.
Clin Sci (Lond). 2023 Apr 26;137(8):597-601. doi: 10.1042/CS20220775.
7
Mass Cytometry Reveals the Imbalanced Immune State in the Peripheral Blood of Patients with Essential Hypertension.
Cardiovasc Ther. 2023 Feb 27;2023:9915178. doi: 10.1155/2023/9915178. eCollection 2023.
9
Lymphatics in Cardiovascular Physiology.
Cold Spring Harb Perspect Med. 2022 Aug 15;12(8):a041173. doi: 10.1101/cshperspect.a041173.

本文引用的文献

1
Enhancing Renal Lymphatic Expansion Prevents Hypertension in Mice.
Circ Res. 2018 Apr 13;122(8):1094-1101. doi: 10.1161/CIRCRESAHA.118.312765. Epub 2018 Feb 23.
2
The immunology of hypertension.
J Exp Med. 2018 Jan 2;215(1):21-33. doi: 10.1084/jem.20171773. Epub 2017 Dec 15.
5
THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: G protein-coupled receptors.
Br J Pharmacol. 2017 Dec;174 Suppl 1(Suppl Suppl 1):S17-S129. doi: 10.1111/bph.13878.
6
THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Overview.
Br J Pharmacol. 2017 Dec;174 Suppl 1(Suppl Suppl 1):S1-S16. doi: 10.1111/bph.13882.
7
THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Catalytic receptors.
Br J Pharmacol. 2017 Dec;174 Suppl 1(Suppl Suppl 1):S225-S271. doi: 10.1111/bph.13876.
8
Chronic Rejection of Cardiac Allografts Is Associated With Increased Lymphatic Flow and Cellular Trafficking.
Circulation. 2018 Jan 30;137(5):488-503. doi: 10.1161/CIRCULATIONAHA.117.028533. Epub 2017 Aug 3.
9
Exploiting lymphatic vessels for immunomodulation: Rationale, opportunities, and challenges.
Adv Drug Deliv Rev. 2017 May 15;114:43-59. doi: 10.1016/j.addr.2017.07.005. Epub 2017 Jul 8.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验